Display search results for ** instead (2 products)

2 Item(s)

11 Nov 2016  |  North America

Global Orphan Drug Market

High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

USD 6,000.00

USD 4,500.00 save 25 %

04 Jul 2016  |  North America

The Global Immuno-oncology Therapeutics Market—Checkpoint Inhibitors

The Next Generation of Cancer Therapies

Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...

USD 8,000.00

USD 6,000.00 save 25 %

2 Item(s)